Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  4,057 results for ""Tissue Plasminogen Activator""

Your Filters

Publisher : public library of science
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Synergistic effects of neuroprotective drugs with intravenous recombinant tissue plasminogen activator in acute ischemic stroke: A Bayesian network meta-analysis.

  • Authors : Dang C; Department of Periodical Press/Chinese Evidence-Based Medicine Center, West China Hospital, Sichuan University, Chengdu, China.; Wang Q

Subjects: Tissue Plasminogen Activator*/Tissue Plasminogen Activator*/Tissue Plasminogen Activator*/administration & dosage ; Tissue Plasminogen Activator*/Tissue Plasminogen Activator*/Tissue Plasminogen Activator*/therapeutic use ; Neuroprotective Agents*/Neuroprotective Agents*/Neuroprotective Agents*/administration & dosage

  • Source: PloS one [PLoS One] 2024 Dec 02; Vol. 19 (12), pp. e0311231. Date of Electronic Publication: 2024 Dec 02 (Print Publication: 2024).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Factors influencing the efficacy of recombinant tissue plasminogen activator: Implications for ischemic stroke treatment.

  • Authors : Víteček J; International Clinical Research Center, St. Anne's University Hospital Brno, Brno, Czech Republic.; Biophysics of Immune System, Institute of Biophysics of the Czech Academy of Sciences, Brno, Czech Republic.

Subjects: Tissue Plasminogen Activator*/Tissue Plasminogen Activator*/Tissue Plasminogen Activator*/therapeutic use ; Ischemic Stroke*/Ischemic Stroke*/Ischemic Stroke*/drug therapy ; Recombinant Proteins*/Recombinant Proteins*/Recombinant Proteins*/therapeutic use

  • Source: PloS one [PLoS One] 2024 Jun 06; Vol. 19 (6), pp. e0302269. Date of Electronic Publication: 2024 Jun 06 (Print Publication: 2024).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Can the combination of antiplatelet or alteplase thrombolytic therapy with argatroban benefit patients suffering from acute stroke? a systematic review, meta-analysis, and meta-regression.

  • Authors : Xie H; Department of Clinical Pharmacy, The Third Hospital of Quzhou, Quzhou, Zhejiang, 324003, China.; Chen Y

Subjects: Arginine*/Arginine*/Arginine*/analogs & derivatives ; Pipecolic Acids*/Pipecolic Acids*/Pipecolic Acids*/therapeutic use ; Pipecolic Acids*/Pipecolic Acids*/Pipecolic Acids*/administration & dosage

  • Source: PloS one [PLoS One] 2024 Feb 27; Vol. 19 (2), pp. e0298226. Date of Electronic Publication: 2024 Feb 27 (Print Publication: 2024).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Risk factors for breakthrough vitreous hemorrhage after intravitreal tissue plasminogen activator and gas injection for submacular hemorrhage associated with age related macular degeneration.

  • Authors : Lim JH; Department of Ophthalmology, Kosin University Hospital, Busan, South Korea.; Han YS

Subjects: Fluorocarbons/Fluorocarbons/Fluorocarbons/*therapeutic use ; Macular Degeneration/Macular Degeneration/Macular Degeneration/*therapy ; Tissue Plasminogen Activator/Tissue Plasminogen Activator/Tissue Plasminogen Activator/*therapeutic use

  • Source: PloS one [PLoS One] 2020 Dec 03; Vol. 15 (12), pp. e0243201. Date of Electronic Publication: 2020 Dec 03 (Print Publication: 2020).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Tissue plasminogen activator dose and pulmonary artery pressure reduction in catheter directed thrombolysis of submassive pulmonary embolism.

  • Authors : Patel DC; Department of Radiology, University of Illinois Health, Chicago, Illinois, United States of America.; Gaba RC

Subjects: Pulmonary Artery*; Blood Pressure/Blood Pressure/Blood Pressure/*drug effects ; Catheterization, Peripheral/Catheterization, Peripheral/Catheterization, Peripheral/*methods

  • Source: PloS one [PLoS One] 2019 Feb 06; Vol. 14 (2), pp. e0211701. Date of Electronic Publication: 2019 Feb 06 (Print Publication: 2019).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Visual prognosis of submacular hemorrhage secondary to age-related macular degeneration: A retrospective multicenter survey.

  • Authors : Inoue N; Department of Ophthalmology and Visual Science, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.; J-CREST (Japanese Clinical Retina Study) Group, Kagoshima, Japan.

Subjects: Macular Degeneration*/Macular Degeneration*/Macular Degeneration*/drug therapy ; Macular Degeneration*/Macular Degeneration*/Macular Degeneration*/therapy ; Tissue Plasminogen Activator*/Tissue Plasminogen Activator*/Tissue Plasminogen Activator*/therapeutic use

  • Source: PloS one [PLoS One] 2022 Jul 21; Vol. 17 (7), pp. e0271447. Date of Electronic Publication: 2022 Jul 21 (Print Publication: 2022).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection

Record details

Read Online Read More Add to Saved list
×
Academic Journal

(More than) doubling down: Effective fibrinolysis at a reduced rt-PA dose for catheter-directed thrombolysis combined with histotripsy.

  • Authors : Hendley SA; Committee on Medical Physics, University of Chicago, Chicago, Illinois, United States of America.; Bhargava A

Subjects: Fibrinolysis/Fibrinolysis/Fibrinolysis/*drug effects ; Fibrinolytic Agents/Fibrinolytic Agents/Fibrinolytic Agents/*pharmacology ; Thrombolytic Therapy/Thrombolytic Therapy/Thrombolytic Therapy/*methods

  • Source: PloS one [PLoS One] 2022 Jan 04; Vol. 17 (1), pp. e0261567. Date of Electronic Publication: 2022 Jan 04 (Print Publication: 2022).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Reteplase Fc-fusions produced in N. benthamiana are able to dissolve blood clots ex vivo.

  • Authors : Izadi S; Department of Applied Genetics and Cell Biology, Natural Resources and Life Sciences, Vienna, Austria.; Faculty of Agriculture, Department of Plant Genetics and Breeding, Tarbiat Modares University, Tehran, Iran.

Subjects: Fibrinolytic Agents*/Fibrinolytic Agents*/Fibrinolytic Agents*/chemistry ; Fibrinolytic Agents*/Fibrinolytic Agents*/Fibrinolytic Agents*/pharmacology ; Immunoglobulin Fc Fragments*/Immunoglobulin Fc Fragments*/Immunoglobulin Fc Fragments*/biosynthesis

  • Source: PloS one [PLoS One] 2021 Nov 30; Vol. 16 (11), pp. e0260796. Date of Electronic Publication: 2021 Nov 30 (Print Publication: 2021).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Functional and structural outcome after vitrectomy combined with subretinal rtPA Injection with or without additional intravitreal Bevacizumab injection for submacular hemorrhages.

  • Authors : Rickmann A; Depatment of Ophthalmology, Knappschaft Hospital Saar, Sulzbach/Saar, Germany.; Paez LR

Subjects: Bevacizumab/Bevacizumab/Bevacizumab/*administration & dosage ; Macular Degeneration/Macular Degeneration/Macular Degeneration/*drug therapy ; Retinal Hemorrhage/Retinal Hemorrhage/Retinal Hemorrhage/*drug therapy

  • Source: PloS one [PLoS One] 2021 Apr 30; Vol. 16 (4), pp. e0250587. Date of Electronic Publication: 2021 Apr 30 (Print Publication: 2021).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Recombinant Tissue Plasminogen Activator Induces Neurological Side Effects Independent on Thrombolysis in Mechanical Animal Models of Focal Cerebral Infarction: A Systematic Review and Meta-Analysis.

  • Authors : Dong MX; Department of Neurology, the First Affiliated Hospital of Chongqing Medical University, Chongqing, China.; Institute of Neuroscience and the Collaborative Innovation Center for Brain Science, Chongqing Medical University, Chongqing, China.

Subjects: Cerebral Infarction/Cerebral Infarction/Cerebral Infarction/*complications ; Stroke/Stroke/Stroke/*complications ; Thrombolytic Therapy/Thrombolytic Therapy/Thrombolytic Therapy/*adverse effects

  • Source: PloS one [PLoS One] 2016 Jul 07; Vol. 11 (7), pp. e0158848. Date of Electronic Publication: 2016 Jul 07 (Print Publication: 2016).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection

Record details

Read Online Read More Add to Saved list
×
  • 1-10 of  4,057 results for ""Tissue Plasminogen Activator""